<DOC>
	<DOCNO>NCT01669668</DOCNO>
	<brief_summary>This phase II trial study effectively radiofrequency ablation prevents recurrence hepatocellular carcinoma ( HCC ) patient easily removable tumor . Radiofrequency ablation use high-frequency , electric current kill tumor cell .</brief_summary>
	<brief_title>Radiofrequency Ablation Treating Patients With Liver Cancer ( Hepatocellular Carcinoma )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Histologically proven HCC unambiguous radiologic finding consistent HCC ( &gt; 1 cm tumor arterial hypervascularity venous delayed phase washout ) patient underlie liver disease . Disease must consider unresectable ( define protocol ) . Age 18 69 ( inclusive ) . Karnofsky performance status ≥ 80 % Normal organ marrow function define : leukocyte ≥3,000/mcL absolute neutrophil count ≥1,500/mcL platelets &gt; 100,000/mcL total bilirubin &lt; 2.0 mg/dL AST ( SGOT ) /ALT ( SGPT ) ≤2.5 X institutional upper limit normal creatinine within normal institutional limit OR creatinine clearance ≥60 mL/min/1.73 m2 patient creatinine level institutional normal Presence ≤ 3 tumor , ≤ 3 cm size . This determine preoperatively confirm intraoperative ultrasound . Liver function ChildPugh class A B Tumor ( ) must 2 cm away major biliary duct major blood vessel define main portal vein right leave primary branch first 1 cm secondary branch common hepatic duct right leave primary branch first 1 cm secondary branch . Able understand willing sign write informed consent document . Hepatic tumor ( ) satellite lesion . A satellite lesion define tumor within 2 cm tumor assess treatment diameter le 33 % diameter tumor assess treatment . Evidence metastatic/extrahepatic disease base abdominal chest CT perform within 4 week procedure . Extrahepatic disease upon laparoscopy perform time RFA . If extrahepatic disease discover laparoscopy , RFA perform , patient consider ineligible study replace . Pregnancy . All woman childbearing potential must negative pregnancy test prior enrollment study . Significant portal hypertension base evidence esophageal varix ascites . Minimal portal hypertension ascites exclusion criterion . Previous history HCC noncutaneous malignancy . Patients find ineligible due intraoperative finding record cause ineligibility . They count accrued patient . Inclusion Women Minorities Both men woman member race ethnic group eligible trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>